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g.2012.0Abstract ‘‘Disorders of Sex Development’’ (DSD) is the state of a person whose sex chromosomes,
genitalia and/or secondary sex characteristics are determined to be neither exclusively male nor
female. The aim of this work was the genetic study of patients with ambiguous genitalia and genetic
counseling of these cases. This study was conducted in the period from November 2007 to February
2009. Cases were obtained from the Genetics and Endocrine Units, Pediatric department, Faculty
of Medicine, Menouﬁya University, Egypt. Thirteen cases with ambiguous genitalia were studied,
10 genetic female and 3 genetic male patients. Their ages ranged from the ﬁrst week to eight years.
All cases were subjected to the following: Detailed history, thorough clinical examination, routine
investigations, hormonal, imaging studies, cytogenetic study and molecular study. Sequencing for
both the SRY and the CYP21 genes and genetic counseling were performed. Study revealed that
among our patients, cases number 2 and 11 were mainly presented as salt losing crisis. Cases 5
and 13 were presented with hirsutism of the external genitalia and upper and lower limbs. Eight
cases (61.5%) had a positive consanguinity and Cases 3 and 4 were sisters. Hormonal study revealed
that (adrenocorticotropic hormone) ACTH, was within the normal range with a mean 83.14 pg/
ml ± 53.6 pg/ml for all patients. Serum Cortisol and 17-OHP (17-hydroxyprogesterone) were ele-
vated in all patients. Karyotype using G-banding showed that there were no apparent anomalies
in the sex chromosomes. We found four cases (30.8%) with different mutations in the SRY gene
at codon Q57R and S143C. As for the CYP21 gene, we found a variety of deletions in size and site
within the structure of the gene in 85.4% of cases leading to alteration in the function of the CYP21
gene which ultimately lead to congenital adrenal hyperplasia (CAH) in these cases.
 2012 Ain Shams University. Production and hosting by Elsevier B.V. All rights reserved.exandria, Egypt. Tel.: +20
(M.A.M. Tawﬁk).
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6.0031. Introduction
Genital anomalies are estimated to occur in 1 in 4,500 births.
The most common cause of ambiguous genitalia in the new-
born is congenital adrenal hyperplasia (CAH) – 1 per 15,000
live births. CAH appears to be more common in those of
European Jewish, Hispanic, Slavic and Italian descent.
The ability to diagnose Developmental Sex Disorders
(DSD) has advanced rapidly in recent years. In most cases
today, clinicians can promptly make an accurate diagnosisier B.V. All rights reserved.
282 S.S.A.E. Ella et al.and counsel parents on therapeutic options [1]. The ultimate
goal in any management strategy is to provide a framework
that will allow the affected child to develop into a well-ad-
justed psychosocially stable individual who identiﬁes with
and is happy in the assigned sex [2]. Factors that inﬂuence
sex assignment include diagnosis, genotype, genital appear-
ance, surgical options, need for lifelong replacement therapy,
potential for fertility, views of the family, and sometimes cir-
cumstances relating to cultural practices [2–4].
The aim of this work was the genetic study (both cytogenet-
ics and molecular genetics) of DSD cases with special promi-
nence of Karyotyping and DNA extraction, PCR, gel
electrophoresis, SSCP and automated DNA sequencing for
both the SRY and the CYP21 genes and genetic counseling
of DSD cases and determination of the causes and/or risk fac-
tors in each case.
2. Patients and methods
2.1. Patients
The study was conducted on 13 children with ambiguous gen-
italia. They were selected from Menouﬁya university hospitals,
Genetics and Endocrine Unit, Pediatric department, Egypt,
during the period from 2007–2009. They were 10 genetic fe-
males and 3 genetic males. Their ages ranged from the ﬁrst
week up to eight years.
2.2. Methods
All studied cases were subjected to the following: A detailed his-
tory with stress on maternal exposure to androgens,
virilization symptoms in the mother or the use of phenytoin
and the presence of similar conditions in the family and family
pedigree.
A thorough clinical examination including general exami-
nation of all systems, body hair distribution (hirsutism) and
skin examination (signs of dehydration).
External genitalia examination with stress on: Phallus: size,
degree of differentiation, length, ventral curvature, appearance
of the foreskin and location of the urethral meatus. We also
used Prader scoring system for this [5]. The scrotum or labia:
were examined for separation and/or fusion between the two
halves of the labioscrotal tissue. Scrotal rugea or labioscrotal
folds with increased pigmentation were noted. Tanner staging
was established and it included examination of the breast in fe-
males, the external genitalia in males and pubic hair in both.
Gonadal examination with stress on its site: (within the labio-
scrotal tissue or outside it), fully descended or not. Also
anthropometric measurements were obtained.
Routine investigations included complete blood picture,
serum electrolytes and glucose levels which were closely mon-
itored in cases with salt losing congenital adrenal hyperplasia
(CAH) especially sodium (Na) and potassium (K).
Hormonal investigations included serum levels of ACTH
(Adrenocorticotropic hormone), Cortisol and 17-OHP (17-
hydroxyprogesterone) [6,7] .
Imaging studies including genitogram and abdomino-pelvic
ultrasound, CT and/or MRI were needed to determine the
presence and/or absence of internal genital structures (such
as undescended testes).Cytogenetic study included chromosomal karyotype using
G-banding [8].
Molecular study: focused mainly on the SRY gene and the
CYP21 gene. The SRY gene is the main regulator of sexual dif-
ferentiation, while the CYP21 gene is the main gene affected in
CAH, the commonest form of Developmental Sex Disorders
(DSD). The following steps were applied:
a. DNA extraction [9].
b. PCR (Polymerase Chain Reaction) [10].
c. Gel electrophoresis [11].
d. SSCP (Single-strand conformational polymorphism)
[12].
e. Automated DNA sequencing [13].
And lastly genetic counseling was done to all families in or-
der to prevent, avoid or ameliorate the disorder [14].
3. Results
The results of this study were illustrated in Tables 1–5 and
Figs. 1–4.
Generally, cases number 2 and 11 were mainly presented as
salt losing crisis in the form of severe, recurrent vomiting, diar-
rhea and dehydration.
Cases 5 and 13 were presented with hirsutism of the exter-
nal genitalia and upper and lower limbs. While cases number 1,
3, 4, 6 to 10 and 12 were mainly presented as ambiguous gen-
italia. Case number 7 was presented by clitoromegaly with no
palpable gonads (as shown in Fig. 1) and case number 9 was
presented with micropenis with bilateral undescended testes
(as shown in Fig. 2).
We must note that the patient number 13 was not subjected
to the molecular study because the patient died before we
could obtain a blood sample.
Demographic data of studied patients (Table 1) showed
that eight cases (61.54%) of the 13 (cases number 1–7 and
11) had positive consanguinity. Cases 3 and 4 were sisters.
Most of the cases had irrelevant maternal history.
Anthropometric measurements (Table 2) showed that 4
patients were less than the 5th centile (2 females, 2 males: cases
2, 8, 11 and 12), 6 patients were within the normal range (5 fe-
males, 1 male: cases 3–6, 9 and 10) and 1 female (case number
1) was above the 95th centile as regards weight, height and
head circumference.
Table 3 showed that Tanner staging in most cases were in
the 1st stage.
Case 1 was a female with a Tanner staging of B1, P3, and
A1, while cases 5 and 13 were females with tanner staging of
B1, P3 and A2. Also this table showed that clitoromegaly
was the most common presentation in our patients (77%).
As regards laboratory investigations (Table 4), hormonal
assay showed that adrenocorticotropic hormone (ACTH) was
within the normal range with a mean 83.14 pg/ml ± 53.6 pg/
ml for all the patients. Serum Cortisol and 17-OHP were ele-
vated in all the patients:
 Cortisol mean levels (±SD) were A.M sample: 59.8 lg/dl
(±62.45 lg/dl) and
P.M sample: 40.58 lg/dl (±11.8 lg /dl).
Table 1 Demographic data of the studied cases.
Serial no. Age Gender
(by
Karyotype)
Birth
order
Maternal
age
(years)
Paternal
age
(years)
Relevant
maternal
history
Relevant
family history
Pedigree
1 5 yrs $ 1st of 2 23 25
2 4.5 mth $ 3rd of 3 28 30
3 5 years $ 1st of 2 24 30 Toxoplasmosis Younger Sister
4 2.5 yrs $ 2nd of 2 Older sister
5 5 yrs $ 2nd of 3 24 37
6 1.5 yrs $ 2nd of 2 28 33
7 6 days $ 3rd of 3 27 31
8 1 day $ 2nd of twin 30 39 PET & PROM >36 h
9 8 day # 3rd of 3 35 45 Gestation D.M &
PROM (10 days)
10 3 days $ 2nd of 2 26 27 Rheumatic Fever and
B.A
11 1 mth # 2nd of 2 21 29
12 1 mth # 1st born 20 24 Recurrent fever due to
tonsillitis treated by
antibiotic under doctor
supervision
One cousin: hydrocele. –
Another
cousin:umbilical and
inguinal hernia
13 8 yrs $ 2nd of twin 32 40 Graves’ disease
(treated during
pregnancy)
B.A: Bronchial Asthma; mth: months; yrs: years; PROM: Premature rupture of membranes; PET: Pre-eclamptic toxemia; $: female; #: male.
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Table 2 Anthropometric measurements of the studied cases.
Serial no. Weight Height BMI (kg/m2) U.S (cm) L.S (cm) U/L ratio Arm span (cm) Head circ.
kg % cm. % cm %
1 25 >95 119.5 >95 17.5 59.5 60 0.99 120 51 >95
2 3 <5 50 <5 12 31.5 18.5 1.71 50 35 <5
3 21 90 110 50–75 17.35 58 52 1.12 110.5 51 50–75
4 14.5 75–90 95 75–90 16 54 41 1.32 94.5 50 75
5 20 75–90 114 90 15.4 60 54 1.11 114 51.5 75
6 12 75–90 83 75 17.42 49.5 33.5 1.48 84 49 90
7 3 5–25 55 75–95 11.09 31 24 1.29 53 35 50
8 2.2 <5 40 <5 13.75 21 19 1.11 41 32 <5
9 4 75–95 48 5–25 17.36 28 20 1.4 47 33 <5
10 3.5 50–75 53 75–95 12.46 31 22 1.41 51 33 10
11 2 <5 50 5–25 8 30 20 1.5 46 29 5–10
12 3 <5 47 <5 13.58 30 17 1.76 48 35 <5
13 21 5–10 125 25–50 13.44 63 62 1.02 125 51 10–25
cm: centimeters; kg: kilograms.
284 S.S.A.E. Ella et al. 17-OHP mean levels (±SD) were Neonates: 1.017 ng/ml
(±0.61 ng/ml) (cases 7–12) and Child: 15.71 ng/ml
(±2.024 ng/ml) (cases 1–6 and13).
Tables 5 and 6 showed that true hermaphrodite can be
diagnosed in two cases (case number 2 and 12) (15.5%) and
the other 10 cases (84.5%) were diagnosed as CAH.
Fig. 3 demonstrates that the SRY gene was not detected
in all the female patients except for case number 2 in which
the SRY gene was detected but in an abnormal position
along the run (at 900 bp). While in the male patients, the
SRY gene was detected in all of them at 650 bp i.e. normal
position. But, in case number 11 it was in an abnormal posi-
tion (at 900 bp). PCR products were scanned for mutations
in the SRY gene using single strand conformational poly-
morphism (SSCP) analysis. All four cases (case 2, 9, 11
and 12) showed aberrant migration in the SSCP assay (as
shown in the Fig. 4).
By direct sequencing of PCR products, we have identiﬁed
three different point mutations in the SRY gene. The ﬁrst
point mutation was the replacement of glutamine with an argi-
nine residue at amino acid 57 in the open reading frame, just
outside and upstream of conserved DNA-binding motif called
HMG box in patients 9, 11 and 12. The second mutation was
the replacement of a tyrosine residue with a phenylalanine
residue at amino acid 127 within the HMG box in patients
2, 9, 11 and 12. The third point mutation was the replacement
of the serine residue at codon 143 with a cysteine residue, just
outside but downstream of the HMG box sequence in patients
2, 9, 11 and 12. The Y127F variant was found in patients 2, 11
and 12. These data suggest that the Y127F variant is a muta-
tion and not a common polymorphism. No nucleotide substi-
tution mutations were found in our preliminary SRY
sequencing from 5 normal males excluding the possibility of
a polymorphism.
The CYP21 gene is located on the short arm of chromo-
some 6 (6p21.3). CYP21 had a variety of deletions within the
structure of the gene in cases 2, 4, 6, 9, 11 and 12. Other cases
had substitution mutations (cases 1–8) where Valine
282ﬁ Leucine. Only one case (case 10) had a normal structure
of the CYP21gene.4. Discussion
In our study, 13 cases were studied of which 10 were conﬁrmed
as females and 3 as males cytogenetically. This is consistent
with the ﬁnding of Anhalt [15] who declared that the most
common presentation of DSD was females (70% of cases).
The maternal history was irrelevant to the disease, as none
of the mothers had a disease before or during the pregnancy.
As for the family history, it was only relevant in one case where
both the sisters were affected by DSD. This was consistent
with the approach taken by Bidarkar [16] who recommended
that the doctor should obtain a full history from the parents
and/or the patient, with the revision of the medical back-
ground of the family, both paternal and maternal side. Also,
he recommended that a family pedigree should be obtained
and structured. Positive consanguinity was found in 8 cases
of our 13 (61.54%). Also, cases 4 and 5 were sisters. Shawky
et al. [17] found a consanguinity rate of 35.3% in Egypt which
helps to accumulate deleterious genes in families. This means
that the high prevalence of consanguinity in our cases is a risk
factor in DSD cases which was also reported by Hashem [18].
All of this is constant with the fact that CAH (the commonest
type of DSD) is autosomal recessive [19,20].
In this study, the presenting manifestation was salt-losing
crisis in two cases (one apparent female, and one apparent
male), hirsutism in another two apparent female cases and
the remaining nine cases were presented as ambiguous external
genitalia. All these presentations were in agreement with the
ﬁndings of Hendren [21] who declared that the signs of DSD
vary from the more obviously apparent, as ambiguous external
genitalia, to the outwardly invisible, as in cases with salt-losing
crisis. As for the anthropometric measurements of the cases, 4
patients were less than the 5th centile, 6 patients were within
the normal range and 1 female was above the 95th centile. This
was constant with the ﬁndings of Boehmer [22] who recom-
mended serial anthropometric measurements to insure that salt
wasting crisis did not cause the child to suffer from stunted
growth. As regards the Tanner staging, most cases were in
the 1st stage except for 3 cases. That meant that most cases
were obtained in the early onset of the disease. This was in
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tor of the hormonal effect on secondary sex characteristics.
The external genital manifestations of the female patients were
mainly as clitoromegaly (76.9%) with no palpable gonads and
three of them (30%) had abnormal growth of pubic hair. Also,
as for the imaging study of the studied group using pelvi-
abdominal ultrasound and MRI, 9 of the 10 females (90%)
had small infantile internal genitalia, while in the remaining
one (10%) no uterus or testis was found. But on the other
hand, this case had a structure like the root of the penis on pel-
vi-abdominal ultrasound. All these ﬁndings were consistent
with the ﬁndings of Bidarkar [16]. Bidarkar explained that
the main external ﬁndings in any apparent female case of
DSD may present with a wide range of presentations begin-
ning from clitoromegaly, fused labia, a concealed vagina or
even an abnormal position of the urethra can be demonstrated.
As for the male patients, the ﬁrst male patient had a micrope-
nis with bilateral undescended testis. The second male patient
had a severe hypospadias with a urethral opening at the tip of
the phallus with bilateral descended testis. In both patients,
pelvi-abdominal ultrasound revealed that there were no
internal female genitalia. All of these previous ﬁndings wereTable 3 Clinical ﬁndings in the studied group.
Serial no. Genitalia Tanner
Breast/ Penis P
1 Clitoromegaly with a single
opening and pubic hair growth
B1 p
2 Clitoromegaly B1 P
3 Clitoromegaly with a single
opening and no palpable gonads
B1 P
4 Clitoromegaly with a single opening
and no palpable gonads
B1 P
5 Clitoromegaly with a single opening
with hair growth over
the mons veneris, no palpable
gonads B1 P
Clitoromegaly with
6 persistent urogenital sinus and
no palpable
B1 P
gonads
7 Clitoromegaly with no palpable gonads B1 P
8 Clitoromegaly with fusion of labia minora
and no alpable gonads
B1 P
9 Micropenis with bilateral descended testis P1 P
10 Clitoromegaly with no palpable gonads B1 P
11 Severe hypospadias with no palpable gonads
12 Direct inguinal hernia with hydrocele
(more on the right side)
with a micropenis with 2
P1 P
openings (one on the tip of the phallus
and the other at the root,
posteriorly). Scrotal sac P1 P
contains testis (at least one on the right
side was felt by palpation)
13 Clitoromegaly with sparse hair growth B1 P
B 1: Breast papillae elevation only;
P1: Either prepubertal penis or prepubertal pubic hair (Villus hair, no co
P2: Minimal, coarse, pigmented hair at base of penis or on the labia;
P3: Coarse, dark curly hair spread over the pubis or over the mons pubi
A1: No axillary hair;
A2: Scanty growth of axillary hair.consistent with the ﬁndings of Nicolino [24]). Nicolino eluci-
dated that the external genital ﬁndings in any apparent male
case of DSD may present with an extensive variety beginning
from unrecognizable male external genitalia, undescended tes-
tes, micropenis, small scrotum with separation or a misplaced
urethral opening. The third male had a micropenis with 2 ure-
thral openings one at the tip of the phallus and the other dor-
sally at the base. Also, there was a direct inguinal hernia with
hydrocele, more on the right side with palpable gonads. The
pelvi-abdominal ultrasound revealed a uterine-like structure
which was conﬁrmed to be a uterus via MRI. When both fe-
male and male genitalia are detected, the patient should be re-
garded as true hermaphrodite [7]. ACTH was within the
normal range, Serum Cortisol and 17-OHP were above the
normal range in all the cases. The measurement of these three
hormones especially 17-OHP is crucial for the construction of
the diagnosis of CAH [6,7].
The genetic study was divided into two main categories:
karyotyping and molecular study. Karyotyping of the cases re-
vealed that all the cases were either apparent females with
46,XX chromosomes or apparent males with 46, XY chromo-
somes i.e., there were no apparent anomalies in the sexN.B
ubic hair Axillary hair Hair distribution
3 A1 Temporal recession
1 A1
1 A1
1 A1
3 A2
1 A1
1 A1
1 A1
1 A1
1 A1
1 A1
1 A1
3 A2 Hirsutism of the UL, LL & mustache area
arse or pigmented hair.);
s;
Table 4 A summary of the ﬁndings in the female patients.
Serial no. Provisional
diagnosis
Age Gender
(Karyotype)
Hormonal assay Imaging study Final
diagnosis
ACTH
(pg/ml)
Cortisol
(lg/dl)
17-OHP
(ng/ml)
Abdominopelvic
U/S
Others
1 Ambiguous
Genitalia
5 Y $(46,XX) 45 AM= 28.5
PM= 31
16.2 Normally developed
female organs
CAH
2 Ambiguous
Genitalia
4.5 M $(46,XX) 37.5 AM= 32
PM= 36.6
15 - Female organs cannot
be detected. Structure
like the root of penis
with no detectable testis
True
hermaphrodite
3 Ambiguous
Genitalia
2.5 Y $(46,XX) 33 AM= 29.8
PM= 42.9
13.4 Well deﬁned retrovasical
structure (1.8 · 1 cm)
seems to be a uterus
MRI: small structure with
in the pelvis, but no deﬁnite
uterus or testicles was found.
CAH
4 Ambiguous
Genitalia
5 Y $(46,XX) 36 AM= 160.6
PM= 72
16.5 Normally developed
uterus but small in size
MRI: infantile uterus with
visualized both ovaries
CAH
5 Hirsutism 5 Y $(46,XX) 39.5 AM= 30
PM= 32.4
14.9 Visible uterus
and ovaries
Genitogram: visualized
uterus and vagina.
CAH
6 Ambiguous
Genitalia
1.5 Y $(46,XX) 29.8 AM> 50
PM> 50
>20 Visible uterus and
ovaries
MRI: infantile uterus
(0.5 · 2.5 · 0.5 cm).
CAH
7 Ambiguous
Genitalia
6 D $(46,XX) 146 AM= 32
PM= 35.4
2 Normal infantile uterus CAH
8 Ambiguous
Genitalia
1 D $(46,XX) 152 AM= 29
PM= 7.1
0.5 Normal infantile uterus CAH
9 Ambiguous
Genitalia
3 D $(46,XX) 156 AM= 37.2
PM= 39
1.4 Normal infantile uterus CAH
10 Hirsutism 8 yrs $(46,XX) 35 AM= 231.2
PM= 51.9
14 Normally developed but
small female organs
CAH
ACTH: adrenocorticotropic hormone, 17-OHP: 17 hydroxyprogesterone.
U/S: ultrasound, CAH: congenital adrenal hyperplasia.
MRI: magnetic resonance imaging.
286 S.S.A.E. Ella et al.chromosomes. Karyotyping is essential for provisional diagno-
sis and classiﬁcation of the DSD cases [25].
As regards the molecular studies, the main genes that we
have focused on were the SRY and the CYP21 genes. That
is because the male genital differentiation mainly relies on
the SRY gene and the most common cause of DSD in females
is CAH (congenital adrenal hyperplasia) which is mainly
caused by a defect in the CYP21 gene. We found four cases
with different mutations in the SRY gene at codon Q57R
and S143C. Both these mutations lie just outside the highly
conserved HMG box. Also, we found that the polar neutral
amino acid, glutamine, is replaced with a polar charged argi-
nine in patients 9, 11 and 12. It is possible that with this muta-
tion in place, the mutated SRY protein may not be able to
enter the nucleus to elicit the male gene expression or it may
have disrupted the nuclear localization signal necessary to per-
form male gene expression. The polar neutral amino acid ser-
ine is found to be replaced with a neutral and non-polar
Cysteine at codon 143 in four patients (2, 9, 11 and 12). This
change may result in an altered SRY protein which may have
lost some of its stabilizing potential [27]. Any mutation in the
SRY gene may cause a defect in its function and that it is
hypothesized that the regions outside the HMG box might
be required to stabilize protein binding and to generate speci-
ﬁcity by helping to discriminate between the protein–protein
interactions [26,27]. As for the case number 2, she was an
apparent female with clitoromegaly and with no internal fe-
male or male genitalia except for a structure like the root of pe-
nis that was detected with abdomino-pelvic U/S. Her
karyotyping was 46,XX and yet she carried the SRY genewhich was found to have several mutations as described above.
The importance of the SRY gene appears when reciprocal
translocation of the SRY gene between Y and X chromosome
takes place which may result in 46,XX with a male genitalia
[28].
As for the CYP21 gene, we found that our studied cases
had a variety of deletions in size and site within the structure
of the gene (cases 2, 4, 6, 9, 11 and 12) which was mainly in
the terminal part of the gene. Other cases had substitution
mutations (cases 1 to 8) where Valine 282ﬁ Leucine. Only
one case (case 10) had a normal structure of the CYP21 gene.
These deletions in the gene caused alteration in the function of
the CYP21 gene which ultimately caused CAH in these cases.
The commonest type of CAH is the deﬁciency of 21 hydroxy-
lase (21-OH) which is carried on two genes – CYP21 (which is
the active gene) and CYP21P – and that any malfunction in
CYP21 will cause hyperfunction and hyperplasia of the adre-
nals, leading to CAH [7,25].
As for Genetic counseling, the patients and their families
were advised of the consequences and nature of the disorder,
the probability of developing or transmitting it. The options
were open to them in management and family planning in or-
der to prevent, avoid or ameliorate DSD. This complex pro-
cess was seen from the diagnostic and the supportive aspects.
The culture of the Middle Eastern families greatly inﬂuenced
our work. This was evident during obtaining the material for
this study. The parents’ main concern was the identiﬁcation
of the child’s gender, not for the relief of this condition, but
for the fear of the stigma associated with gender re-assignment.
The spectrum of DSD can pose a diagnostic dilemma and
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Figure 2 External genital appearance for case 7 demonstrating
Clitoromegaly with no palpable gonads.
Figure 1 External genital appearance of case 9 demonstrating
micropenis with bilateral undescended testes.
Cytogenetic and molecular study in intersex 287there will be strong pressures, especially from the parents, to
provide a rapid gender determination with limited information
[29,30]. We found this to be true in all of our 13 cases with no
discrimination between the attitudes of the male or female pa-
tients’ families. The parents of the patients were anxious to
know their children’s condition. A dispute that we had to face
was the parents urge that we would reach a diagnosis as soon
as possible. This was met from our side with assurance that the
condition can be diagnosed only after completion of the
appropriate and full anatomical, biochemical and multidisci-
plinary evaluation before rushing to an arbitrary gender
assignment. It was a challenge to convince the parents with
the importance of these tests and evaluations before rushing
into any decision making. Hughes [4] also recommended that
we should inform the parents that the gender chosen by the
parents and health care providers on behalf of the patient or
against his or her will may not be the same gender later chosen
by the patient. This was informed to the patients and their par-
ents as well as the other members of the multidisciplinary
team. Our multidisciplinary team consisted of a neonatologist,
a geneticist, an endocrinologist and a pediatric surgeon. A psy-
chological consultation was provided when necessary. All
these were tried to remain foremost focused on the child’s
Figure 3 Gel electrophoresis of the PCR amplicons of the SRY gene.  Lane M: DNA ladder of 100 bp starting from 500 to 1000 bp. 
Lanes P1ﬁP8 and P10: SRY ampliﬁcation for Egyptian female patients.  Lanes P9, P11 and P12: SRY ampliﬁcation for the Egyptian
male patients.  Lanes C1ﬁC5: SRY ampliﬁcation for a normal male.
Figure 4 SSCP analysis of SRY gene in the studied cases.  Lanes N1: SRY negative control DNA (i.e., 46,XX)  Lanes C1ﬁC5: SRY
gene positive control DNA.  P 2, 9, 11 and 12: SRY gene with missing bands, shown with the upper arrows, indicating that these patients
carry mutations in the SRY gene. Also, the lower arrows correspond to the missing area which was detected in the control.).
288 S.S.A.E. Ella et al.needs. Joel [27] also recommended the use of the multidisci-
plinary team but he added the use of counselors and ethicists.
We replaced both with a psychiatrist, when needed, and, most
importantly, our own ethics and moral values were our care
guidance.
We recommend that determination of the sex is an emer-
gency as it requires examination of the external genitalia dur-
ing routine examination of the child. Assignment of sex is very
crucial, yet, speed is not a part of the diagnosis. Early manage-
ment of DSD is crucial to prevent the complications which are
either the salt-losing crisis or the psychic impact of the condi-
tion on both the patient and the family. Management of DSD
should not be decided under the inﬂuence of the parents or the
doctors, but only under the inﬂuence of the child’s welfare.A communication system between Genetic and Endocrine
Centers all over Egypt is a crucial and important part in the
management of DSD and we are hopefully aiming toward
the application of the SRY gene molecular study as a routine
part of the investigations of DSD. Also, genetic counseling is a
crucial part in the management of DSD cases which was ad-
dressed to both the patient and the family.
As a conclusion, our study focused on the importance of
early diagnosis, early treatment and early counseling to all
our studied cases. It was crucial to approach the families in
a direct, yet simple, way. Once DSD is suspected, doctors
should not hesitate to inform the parents about their child’s
condition and proceed to identify and diagnose the cause ﬁrst
then the gender.
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